Secondary outcomes
high-grade lesions, dysplasia, carcinoma
DYSPLASIA, CARCINOMA
The following outcomes will be collected from the implementation practices (offering HPV self-testing):Proportion of women having an HPV self-test.Proportion of women having either an HPV self-test, clinician-administered HPV test or cervical cytology (uptake of screening).Proportion of women with a positive result for high-risk HPV (HPV16, HPV18 or HPV ‘Other’).Proportion of women who have cervical cytology following a positive result for HPV ‘Other’.Proportion of women who return for an HPV test after one year following a positive result for HPV ‘Other’ and a negative/mild dysplasia cytology result.Proportion of women attending colposcopy following a positive result for HPV16 or HPV18.Prevalence of high-grade lesions (CIN2, CIN3, carcinoma) among women attending colposcopy.These outcomes will be stratified by, or adjusted for, ethnicity, deprivation index and screening history to understand screening uptake and post-screening care pathways in these groups.